Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor- Positive Endometrial Cancer

The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial cancers that overexpress folate receptor alpha (FR).

adenocarcinoma
endometrial carcinoma
recurrent disease
mirvetuximab soravtansine
recurrent endometrial cancer
  • 0 views
  • 02 May, 2021
  • 1 location
The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate

University Hospital (NTUH). Some cytokines that will be measured include vasculoendothelial growth factor, hyaluronan, transforming growth factor-β, procollagen, and cancer antigen-125. The same

  • 0 views
  • 07 Nov, 2020